{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:58:32Z","timestamp":1791172712709,"version":"4.1.0"},"reference-count":128,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7,1]]},"abstract":"<jats:p>Background. Acute chest syndrome (ACS) is the leading cause of hospitalization, morbidity, and mortality in patients with sickle cell disease. Radiographic and clinical findings in ACS resemble pneumonia; however, etiologies other than infectious pathogens have been implicated, including pulmonary fat embolism (PFE) and infarction of segments of the pulmonary vasculature. The National Acute Chest Syndrome Study Group was designed to identify the etiologic agents and clinical outcomes associated with this syndrome.<\/jats:p>\n               <jats:p>Methods. Data were analyzed from the prospective study of 671 episodes of ACS in 538 patients with sickle cell anemia. ACS was defined as a new pulmonary infiltrate involving at least 1 complete segment of the lung, excluding atelectasis. In addition, the patients had to have chest pain, fever &amp;gt;38.5C, tachypnea, wheezing, or cough. Samples of blood and deep sputum were analyzed for evidence of bacteria, viruses, and PFE. Mycoplasma pneumoniae infection was determined by analysis of paired serologies. Detailed information on patient characteristics, presenting signs and symptoms, treatment, and clinical outcome were collected.<\/jats:p>\n               <jats:p>Results. Fifty-one (9%) of 598 episodes of ACS had serologic evidence of M pneumoniae infection. Twelve percent of the 112 episodes of ACS occurring in patients younger than 5 years were associated with M pneumoniae infection. At the time of diagnosis, 98% of all patients with M pneumoniae infection had fever, 78% had a cough, and 51% were tachypneic. More than 50% developed multilobar infiltrates and effusions, 82% were transfused, and 6% required assisted ventilation. The average hospital stay was 10 days. Evidence of PFE with M pneumoniae infection was seen in 5 (20%) of 25 patients with adequate deep respiratory samples for the PFE assay. M pneumoniae and Chlamydia pneumoniae was found in 16% of patients with diagnostic studies for C pneumoniae. Mycoplasma hominis was cultured in 10 (2%) of 555 episodes of ACS and occurred more frequently in older patients, but the presenting symptoms and clinical course was similar to those with M pneumoniae.<\/jats:p>\n               <jats:p>Conclusions. M pneumoniae is commonly associated with the ACS in patients with sickle cell anemia and occurs in very young children. M hominis should be considered in the differential diagnosis of ACS. Aggressive treatment with broad-spectrum antibiotics, including 1 from the macrolide class, is recommended for all patients as well as bronchodilator therapy, early transfusion, and respiratory support when clinically indicated.<\/jats:p>","DOI":"10.1542\/peds.112.1.87","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"87-95","source":"Crossref","is-referenced-by-count":70,"title":["<i>Mycoplasma<\/i> Disease and Acute Chest Syndrome in Sickle Cell Disease"],"prefix":"10.1542","volume":"112","author":[{"given":"Lynne","family":"Neumayr","sequence":"first","affiliation":[{"name":"Hematology\/Oncology Department, Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lennette","sequence":"additional","affiliation":[{"name":"Virolab, Inc, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Kelly","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Department, Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Earles","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Department, Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Embury","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Groncy","sequence":"additional","affiliation":[{"name":"Hematology Department, Long Beach Memorial Hospital, Long Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Grossi","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Department, Children\u2019s Hospital of Buffalo, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeet","family":"Grover","sequence":"additional","affiliation":[{"name":"Comprehensive Sickle Cell Center, St Luke\u2019s\/Roosevelt Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"McMahon","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Division of Hematology, Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Waldron","sequence":"additional","affiliation":[{"name":"Health Sciences Center, Department of Pediatrics, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Department, Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,7,1]]},"reference":[{"key":"2021121003391260100_R1","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. [erratum appears in N Engl J Med 2000 Sep 14;343:824]. N Engl J Med.2000;342:1855\u20131865","DOI":"10.1056\/NEJM200006223422502"},{"key":"2021121003391260100_R2","doi-asserted-by":"crossref","unstructured":"Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J.1995;14:471\u2013477","DOI":"10.1097\/00006454-199506000-00002"},{"key":"2021121003391260100_R3","doi-asserted-by":"crossref","unstructured":"Bochud PY, Moser F, Erard P, et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore).2001;80:75\u201387","DOI":"10.1097\/00005792-200103000-00001"},{"key":"2021121003391260100_R4","doi-asserted-by":"crossref","unstructured":"Drummond P, Clark J, Wheeler J, Galloway A, Freeman R, Cant A. Community acquired pneumonia\u2014a prospective UK study. Arch Dis Child.2000;83:408\u2013412","DOI":"10.1136\/adc.83.5.408"},{"key":"2021121003391260100_R5","doi-asserted-by":"crossref","unstructured":"Foy HM. Mycoplasma pneumoniae pneumonia: current perspectives. Clin Infect Dis.1999;28:237","DOI":"10.1086\/515118"},{"key":"2021121003391260100_R6","doi-asserted-by":"crossref","unstructured":"Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA.1996;275:134\u2013141","DOI":"10.1001\/jama.275.2.134"},{"key":"2021121003391260100_R7","doi-asserted-by":"crossref","unstructured":"Chan CH, Cohen M, Pang J. A prospective study of community-acquired pneumonia in Hong Kong. Chest.1992;101:442\u2013446","DOI":"10.1378\/chest.101.2.442"},{"key":"2021121003391260100_R8","doi-asserted-by":"crossref","unstructured":"Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J.1998;17:865\u2013871","DOI":"10.1097\/00006454-199810000-00004"},{"key":"2021121003391260100_R9","doi-asserted-by":"crossref","unstructured":"Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J.1998;17:986\u2013991","DOI":"10.1097\/00006454-199811000-00004"},{"key":"2021121003391260100_R10","doi-asserted-by":"crossref","unstructured":"Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J.2000;19:293\u2013298","DOI":"10.1097\/00006454-200004000-00006"},{"key":"2021121003391260100_R11","doi-asserted-by":"crossref","unstructured":"Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax.2001;56:296\u2013301","DOI":"10.1136\/thorax.56.4.296"},{"key":"2021121003391260100_R12","doi-asserted-by":"crossref","unstructured":"Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med.1996;101:508\u2013515","DOI":"10.1016\/S0002-9343(96)00255-0"},{"key":"2021121003391260100_R13","doi-asserted-by":"crossref","unstructured":"Murphy TF, Henderson FW, Clyde WA, Jr, Collier AM, Denny FW. Pneumonia: an eleven-year study in a pediatric practice. Am J Epidemiol.1981;113:12\u201321","DOI":"10.1093\/oxfordjournals.aje.a113061"},{"key":"2021121003391260100_R14","doi-asserted-by":"crossref","unstructured":"Patel T, Pearl J, Williams J, Haverstock D, Church D. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group. Respir Med.2000;94:97\u2013105","DOI":"10.1053\/rmed.1999.0710"},{"key":"2021121003391260100_R15","doi-asserted-by":"crossref","unstructured":"Sopena N, Sabria M, Pedro-Botet ML, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis.1999;18:852\u2013858","DOI":"10.1007\/s100960050419"},{"key":"2021121003391260100_R16","doi-asserted-by":"crossref","unstructured":"Waris ME, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol.1998;36:3155\u20133159","DOI":"10.1128\/JCM.36.11.3155-3159.1998"},{"key":"2021121003391260100_R17","doi-asserted-by":"crossref","unstructured":"Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J.1999;18:98\u2013104","DOI":"10.1097\/00006454-199902000-00004"},{"key":"2021121003391260100_R18","doi-asserted-by":"crossref","unstructured":"Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J.1989;8:856\u2013862","DOI":"10.1097\/00006454-198912000-00006"},{"key":"2021121003391260100_R19","doi-asserted-by":"crossref","unstructured":"Ruiz-Gonzalez A, Falguera M, Nogjes A, Rubio-Caballero M. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med.1998;106:385\u2013390","DOI":"10.1016\/S0002-9343(99)00050-9"},{"key":"2021121003391260100_R20","doi-asserted-by":"crossref","unstructured":"Mezarina KB, Huffmire A, Downing J, Core N, Gersham K, Hoffman R, from the Centers for Disease Control and Prevention. Outbreak of community-acquired pneumonia caused by Mycoplasma pneumoniae\u2014Colorado, 2000. JAMA.2001;285:2073\u20132074","DOI":"10.1001\/jama.285.16.2073"},{"key":"2021121003391260100_R21","doi-asserted-by":"crossref","unstructured":"Evatt BL, Dowdle WR, Johnson M, Jr, Heath CW, Jr. Epidemic Mycoplasma pneumonia. N Engl J Med.1971;285:374\u2013378","DOI":"10.1056\/NEJM197108122850704"},{"key":"2021121003391260100_R22","doi-asserted-by":"crossref","unstructured":"Foy HM, Kenny GE, McMahan R, Mansy AM, Grayston JT. Mycoplasma pneumoniae pneumonia in an urban area. JAMA.1970;214:1666\u20131672","DOI":"10.1001\/jama.214.9.1666"},{"key":"2021121003391260100_R23","doi-asserted-by":"crossref","unstructured":"Cimolai N, Wensley D, Seear M, Thomas ET. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis.1995;21:1182\u20131185","DOI":"10.1093\/clinids\/21.5.1182"},{"key":"2021121003391260100_R24","unstructured":"Chian CF, Chang FY. Acute respiratory distress syndrome in Mycoplasma pneumonia: a case report and review. J Microbiol Immunol Infect.1999;32:52\u201356"},{"key":"2021121003391260100_R25","unstructured":"Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med.1995;162:133\u2013142"},{"key":"2021121003391260100_R26","doi-asserted-by":"crossref","unstructured":"Chapman RS, Henderson FW, Clyde WA, Collier AM, Denny FW. The epidemiology of tracheobronchitis in pediatric practice. Am J Epidemiol.1981;114:786\u2013797","DOI":"10.1093\/oxfordjournals.aje.a113249"},{"key":"2021121003391260100_R27","unstructured":"Hanhan U, Oriowski J, Fiallos M. Association of Mycoplasma pneumonia infections with status asthmaticus. Pediatrics.1999;104:680"},{"key":"2021121003391260100_R28","doi-asserted-by":"crossref","unstructured":"Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. [erratum appears in Am J Respir Crit Care Med 1998 Nov;158:1692]. Am J Respir Crit Care Med.1998;158:998\u20131001","DOI":"10.1164\/ajrccm.158.3.9711092"},{"key":"2021121003391260100_R29","doi-asserted-by":"crossref","unstructured":"Lamont J, Verbeken E, Verschakelen J, Demedts M. Bronchiolitis obliterans organising pneumonia. A report of 11 cases and a review of the literature. Acta Clin Belg.1998;53:328\u2013336","DOI":"10.1080\/17843286.1998.11754185"},{"key":"2021121003391260100_R30","doi-asserted-by":"crossref","unstructured":"Chan PW, Muridan R, Debruyne JA. Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology.2000;5:369\u2013375","DOI":"10.1111\/j.1440-1843.2000.00277.x"},{"key":"2021121003391260100_R31","doi-asserted-by":"crossref","unstructured":"Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis.2000;31:1507\u20131511","DOI":"10.1086\/317498"},{"key":"2021121003391260100_R32","doi-asserted-by":"crossref","unstructured":"Shah DC, Muthiah MM. Adult respiratory distress syndrome due to Mycoplasma pneumonia. Postgrad Med J.1996;72:241\u2013242","DOI":"10.1136\/pgmj.72.846.241"},{"key":"2021121003391260100_R33","doi-asserted-by":"crossref","unstructured":"Sands MJ, Jr, Satz JE, Turner WE, Jr, Soloff LA. Pericarditis and perimyocarditis associated with active Mycoplasma pneumoniae infection. Ann Intern Med.1977;86:544\u2013548","DOI":"10.7326\/0003-4819-86-5-544"},{"key":"2021121003391260100_R34","doi-asserted-by":"crossref","unstructured":"Kenney RT, Li JS, Clyde WA, Jr, et al. Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis.1993;17(Suppl 1):S58\u2013S62","DOI":"10.1093\/clinids\/17.Supplement_1.S58"},{"key":"2021121003391260100_R35","doi-asserted-by":"crossref","unstructured":"Meseguer MA, Perez-Molina JA, Fernandez-Bustamante J, Gomez R, Martos I, Quero MC. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr Infect Dis J.1996;15:829\u2013831","DOI":"10.1097\/00006454-199609000-00019"},{"key":"2021121003391260100_R36","doi-asserted-by":"crossref","unstructured":"Mattila PS, Carlson P, Sivonen A, et al. Life-threatening Mycoplasma hominis mediastinitis. Clin Infect Dis.1999;29:1529\u20131537","DOI":"10.1086\/313529"},{"key":"2021121003391260100_R37","doi-asserted-by":"crossref","unstructured":"Haier J, Nasralla M, Franco AR, Nicolson GL. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Rheumatology (Oxford).1999;38:504\u2013509","DOI":"10.1093\/rheumatology\/38.6.504"},{"key":"2021121003391260100_R38","doi-asserted-by":"crossref","unstructured":"Poggio TV, Orlando N, Galanternik L, Grinstein S. Microbiology of acute arthropathies among children in Argentina: Mycoplasma pneumoniae and hominis and Ureaplasma urealyticum. Pediatr Infect Dis J.1998;17:304\u2013308","DOI":"10.1097\/00006454-199804000-00007"},{"key":"2021121003391260100_R39","doi-asserted-by":"crossref","unstructured":"Nathan MD. Stevens-Johnson syndrome: twenty-three cases and their otolaryngologic significance. Laryngoscope.1975;85:1713\u20131724","DOI":"10.1288\/00005537-197510000-00013"},{"key":"2021121003391260100_R40","doi-asserted-by":"crossref","unstructured":"Villiger RM, von Vigier RO, Ramelli GP, Hassink RI, Bianchetti MG. Precipitants in 42 cases of erythema multiforme. Eur J Pediatr.1999;158:929\u2013932","DOI":"10.1007\/s004310051244"},{"key":"2021121003391260100_R41","doi-asserted-by":"crossref","unstructured":"Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol.1998;37:667\u2013672","DOI":"10.1046\/j.1365-4362.1998.00316.x"},{"key":"2021121003391260100_R42","doi-asserted-by":"crossref","unstructured":"Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis.2001;32:1674\u20131684","DOI":"10.1086\/320748"},{"key":"2021121003391260100_R43","doi-asserted-by":"crossref","unstructured":"Dionisio D, Valassina M, Mata S, et al. Encephalitis caused directly by Mycoplasma pneumoniae. Scand J Infect Dis.1999;31:506\u2013509","DOI":"10.1080\/00365549950164067"},{"key":"2021121003391260100_R44","doi-asserted-by":"crossref","unstructured":"Ieven M, Demey H, Ursi D, Van Goethem G, Cras P, Goossens H. Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction. Clin Infect Dis.1998;27:1552\u20131553","DOI":"10.1086\/517753"},{"key":"2021121003391260100_R45","doi-asserted-by":"crossref","unstructured":"Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994\u20131995. Clin Infect Dis.1998;26:398\u2013409","DOI":"10.1086\/516301"},{"key":"2021121003391260100_R46","doi-asserted-by":"crossref","unstructured":"Benito-Leon J, Guerrero AL, Simon R, Mateos F. Ischemic stroke in children. Revista de Nerologia.1998;27:631\u2013634","DOI":"10.33588\/rn.27158.98371"},{"key":"2021121003391260100_R47","unstructured":"Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis.1980;122:491\u2013496"},{"key":"2021121003391260100_R48","doi-asserted-by":"crossref","unstructured":"Chusid MJ, Lachman BS, Lazerson J. Severe Mycoplasma pneumonia and vesicular eruption in SC hemoglobinopathy. J Pediatr.1978;93:449\u2013451","DOI":"10.1016\/S0022-3476(78)81156-1"},{"key":"2021121003391260100_R49","doi-asserted-by":"crossref","unstructured":"Davies SC, Luce PJ, Win AA, Riordan JF, Brozovic M. Acute chest syndrome in sickle-cell disease. Lancet.1984;1:36\u201338","DOI":"10.1016\/S0140-6736(84)90193-4"},{"key":"2021121003391260100_R50","unstructured":"Lobel JS, Sturm R, Carroll WL, Limouze SC. Mycoplasma pneumonia in a 15-month-old girl with hemoglobin SC disease. Am J Pediatr Hematol-Oncol.1981;3:444\u2013446"},{"key":"2021121003391260100_R51","doi-asserted-by":"crossref","unstructured":"Maitre B, Habibi A, Roudot-Thoraval F, et al. Acute chest syndrome in adults with sickle cell disease. Chest.2000;117:1386\u20131392","DOI":"10.1378\/chest.117.5.1386"},{"key":"2021121003391260100_R52","doi-asserted-by":"crossref","unstructured":"Miller ST, Hammerschlag MR, Chirgwin K, et al. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr.1991;118:30\u201333","DOI":"10.1016\/S0022-3476(05)81839-6"},{"key":"2021121003391260100_R53","doi-asserted-by":"crossref","unstructured":"Shulman ST, Bartlett J, Clyde WA, Jr, Ayoub EM. The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med.1972;287:164\u2013167","DOI":"10.1056\/NEJM197207272870403"},{"key":"2021121003391260100_R54","unstructured":"Raouf H, Balkis M, Emna G, et al. Complications pulmonaires au cours des syndromes drepanocytaires. Tunis Med.2000;78:176\u2013180"},{"key":"2021121003391260100_R55","doi-asserted-by":"crossref","unstructured":"Srair HA, Owa JA, Aman HA, Madan MA. Acute chest syndrome in children with sickle cell disease. Indian J Pediatr.1995;62:201\u2013205","DOI":"10.1007\/BF02752326"},{"key":"2021121003391260100_R56","unstructured":"Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, ed. Manual of Clinical Microbiology. 7th ed. Washington DC: ASM Press; 1999:782\u2013806"},{"key":"2021121003391260100_R57","unstructured":"Landry ML, Hsiung GD. Primary isolation of viruses. In: Spector S, Lancz G, eds. Clinical Virology Manual. 2nd ed. New York, NY: Elsevier Science Publishing; 1992:43\u201369"},{"key":"2021121003391260100_R58","unstructured":"Lennette ET, Lennette DA. Immune adherence hemagglutination. In: Specter SLG, ed. Clinical Virology Manual. 2nd ed. New York: Elsevier Science Publishing; 1992:251\u2013261"},{"key":"2021121003391260100_R59","unstructured":"Robinson DT. Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press; 1995:652\u2013662"},{"key":"2021121003391260100_R60","doi-asserted-by":"crossref","unstructured":"Kajigaya S, Shimada T, Fujita S, Young NS. A genetically engineered cell linje that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A.1989;86:7601\u20137605","DOI":"10.1073\/pnas.86.19.7601"},{"key":"2021121003391260100_R61","unstructured":"Lennette ET. Epstein-Barr virus. Manual of Clinical Microbiology. 7th ed. Washington DC: ASM Press; 1999:912\u2013918"},{"key":"2021121003391260100_R62","unstructured":"Schachter J. Chlamydia. In: Balows A, Hausler WJJ, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology. 5th ed. Washington DC: ASM Press; 1991:1045\u20131053"},{"key":"2021121003391260100_R63","doi-asserted-by":"crossref","unstructured":"Lietman T, Brooks D, Moncada J, Schachter J, Dawson C, Dean D. Chronic follicular conjuncitivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis.1998;26:1335\u20131340","DOI":"10.1086\/516373"},{"key":"2021121003391260100_R64","doi-asserted-by":"crossref","unstructured":"Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood.1994;83:3107\u20133112","DOI":"10.1182\/blood.V83.11.3107.bloodjournal83113107"},{"key":"2021121003391260100_R65","unstructured":"Kenny GE. Mycoplasmas. In: Balows A, Hausler WJJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology. 5th ed. Washington DC: American Society for Microbiology; 1991:478\u2013481"},{"key":"2021121003391260100_R66","doi-asserted-by":"crossref","unstructured":"Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol.1999;37:14\u201317","DOI":"10.1128\/JCM.37.1.14-17.1999"},{"key":"2021121003391260100_R67","doi-asserted-by":"crossref","unstructured":"Abele-Horn M, Busch U, Nitschko H, et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol.1998;36:548\u2013551","DOI":"10.1128\/JCM.36.2.548-551.1998"},{"key":"2021121003391260100_R68","doi-asserted-by":"crossref","unstructured":"Freymuth F, Vabret A, Brouard J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol.1999;13:131\u2013139","DOI":"10.1016\/S1386-6532(99)00030-X"},{"key":"2021121003391260100_R69","doi-asserted-by":"crossref","unstructured":"Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods.2000;41:45\u201351","DOI":"10.1016\/S0167-7012(00)00135-4"},{"key":"2021121003391260100_R70","doi-asserted-by":"crossref","unstructured":"Menendez R, Cordoba J, de La Cuarda P, et al. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med.1999;159:1868\u20131873","DOI":"10.1164\/ajrccm.159.6.9807070"},{"key":"2021121003391260100_R71","doi-asserted-by":"crossref","unstructured":"Skakni L, Sardet A, Just J, et al. Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction. J Clin Microbiol.1992;30:2638\u20132643","DOI":"10.1128\/jcm.30.10.2638-2643.1992"},{"key":"2021121003391260100_R72","doi-asserted-by":"crossref","unstructured":"Delatte SJ, Hebra A, Tagge EP, Jackson S, Jacques K, Othersen HB, Jr. Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg.1999;34:188\u2013191; discussion 191\u2013182","DOI":"10.1016\/S0022-3468(99)90254-3"},{"key":"2021121003391260100_R73","doi-asserted-by":"crossref","unstructured":"Mallouh AA, Asha M. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child.1988;142:178\u2013182","DOI":"10.1001\/archpedi.1988.02150020080034"},{"key":"2021121003391260100_R74","unstructured":"Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol-Oncol.1986;8:105\u2013110"},{"key":"2021121003391260100_R75","doi-asserted-by":"crossref","unstructured":"Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr.1985;107:861\u2013866","DOI":"10.1016\/S0022-3476(85)80176-1"},{"key":"2021121003391260100_R76","doi-asserted-by":"crossref","unstructured":"Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis.1992;11:217\u2013223","DOI":"10.1007\/BF02098083"},{"key":"2021121003391260100_R77","doi-asserted-by":"crossref","unstructured":"Denny FW, Clyde WA, Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr.1986;108:635\u2013646","DOI":"10.1016\/S0022-3476(86)81034-4"},{"key":"2021121003391260100_R78","doi-asserted-by":"crossref","unstructured":"Davies HD. Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants. Pediatr Infect Dis J.1996;15:371\u2013375","DOI":"10.1097\/00006454-199604000-00017"},{"key":"2021121003391260100_R79","unstructured":"O\u2019Handley JG, Gray LD. The incidence of Mycoplasma pneumoniae pneumonia. J Am Board Fam Pract.1997;10:425\u2013429"},{"key":"2021121003391260100_R80","unstructured":"Fernald GW, Collier AM, Clyde WA, Jr. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics.1975;55:327\u2013335"},{"key":"2021121003391260100_R81","doi-asserted-by":"crossref","unstructured":"Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med.1993;153:488\u2013494","DOI":"10.1001\/archinte.153.4.488"},{"key":"2021121003391260100_R82","doi-asserted-by":"crossref","unstructured":"Becton DL, Friedman HS, Kurtzberg J, Chaffee S, Falletta JM, Kinney TR. Severe Mycoplasma pneumonia in three sisters with sickle cell disease. Pediatr Hematol Oncol.1986;3:259\u2013265","DOI":"10.3109\/08880018609031225"},{"key":"2021121003391260100_R83","doi-asserted-by":"crossref","unstructured":"Solanki DL, Berdoff RL. Severe Mycoplasma pneumonia with pleural effusions in a patient with sickle cell-hemoglobin C(SC) disease. Case report and review of the literature. Am J Med.1979;66:707\u2013710","DOI":"10.1016\/0002-9343(79)91189-6"},{"key":"2021121003391260100_R84","doi-asserted-by":"crossref","unstructured":"Cimolai N. Mycoplasma pneumoniae respiratory infection. Pediatr Rev.1998;19:327\u2013332","DOI":"10.1542\/pir.19-10-327"},{"key":"2021121003391260100_R85","unstructured":"Kozliuk AS. Elektronno-mikroskopicheskoe issledovanie organov dykhaniia pri eksperimental\u2019nom respiratornom mikoplazmoze. Arkh Patol.1980;42:34\u201340"},{"key":"2021121003391260100_R86","unstructured":"Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med.1986;110:34\u201341"},{"key":"2021121003391260100_R87","doi-asserted-by":"crossref","unstructured":"Sokolova IA, Vaughan AT, Khodarev NN. Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s). Immunol Cell Biol.1998;76:526\u2013534","DOI":"10.1046\/j.1440-1711.1998.00781.x"},{"key":"2021121003391260100_R88","doi-asserted-by":"crossref","unstructured":"Opitz O, Pietsch K, Ehlers S, Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology.1996;196:575\u2013587","DOI":"10.1016\/S0171-2985(97)80073-3"},{"key":"2021121003391260100_R89","doi-asserted-by":"crossref","unstructured":"Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev (Washington, DC).1998;62:1094\u20131156","DOI":"10.1128\/MMBR.62.4.1094-1156.1998"},{"key":"2021121003391260100_R90","doi-asserted-by":"crossref","unstructured":"Aldrich TK, Dhuper SK, Patwa NS, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol.1996;80:531\u2013539","DOI":"10.1152\/jappl.1996.80.2.531"},{"key":"2021121003391260100_R91","doi-asserted-by":"crossref","unstructured":"Hebbel RP, Visser MR, Goodman JL, et al. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest.1987;80:1503\u20131506","DOI":"10.1172\/JCI113233"},{"key":"2021121003391260100_R92","doi-asserted-by":"crossref","unstructured":"Smolinski PA, Offermann MK, Eckman JR, Wick TM. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood.1995;85:2945\u20132950","DOI":"10.1182\/blood.V85.10.2945.bloodjournal85102945"},{"key":"2021121003391260100_R93","doi-asserted-by":"crossref","unstructured":"Kragsbjerg P, Jones I, Vikerfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax.1995;50:1253\u20131257","DOI":"10.1136\/thx.50.12.1253"},{"key":"2021121003391260100_R94","unstructured":"Hsieh CC, Tang RB, Tsai CH, Chen W. Serum interleukin-6 and tumor necrosis factor-\u03b1 concentrations in children with Mycoplasma pneumonia. J Microbiol Immunol Infect.2001;34:109\u2013112"},{"key":"2021121003391260100_R95","doi-asserted-by":"crossref","unstructured":"Kragsbjerg P, Vikerfors T, Holmberg H. Cytokine responses in patients with pneumonia caused by Chlamydia or Mycoplasma. Respiration.1998;65:299\u2013303","DOI":"10.1159\/000029280"},{"key":"2021121003391260100_R96","doi-asserted-by":"crossref","unstructured":"Suga M, Ando M, Nishikawa H, Araki S. Adenosine deaminase activity and free IL-2 receptor levels in serum from patients with Mycoplasma pneumonia. Jpn J Med.1991;30:108\u2013112","DOI":"10.2169\/internalmedicine1962.30.108"},{"key":"2021121003391260100_R97","doi-asserted-by":"crossref","unstructured":"Koh YY, Park Y, Lee HJ, Kim CK. Levels of interleukin-2, interferon-\u03b3, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics.2001;107(3). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/3\/e39","DOI":"10.1542\/peds.107.3.e39"},{"key":"2021121003391260100_R98","unstructured":"Tsunekawa H, Takagi E, Kishimoto H, Shimokata K. Depressed cellular immunity in Mycoplasma pneumoniae pneumonia. Eur J Respir Dis.1987;70:293\u2013299"},{"key":"2021121003391260100_R99","unstructured":"Overturf GD. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis.1999;14:191\u2013218"},{"key":"2021121003391260100_R100","doi-asserted-by":"crossref","unstructured":"Taylor SC, Shacks SJ, Mitchell RA. In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J.1996;15:340\u2013344","DOI":"10.1097\/00006454-199604000-00011"},{"key":"2021121003391260100_R101","doi-asserted-by":"crossref","unstructured":"Daian CM, Wolff AH, Bielory L. The role of atypical organisms in asthma. Allergy Asthma Proc.2000;21:107\u2013111","DOI":"10.2500\/108854100778250860"},{"key":"2021121003391260100_R102","doi-asserted-by":"crossref","unstructured":"Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child.1984;59:1034\u20131037","DOI":"10.1136\/adc.59.11.1034"},{"key":"2021121003391260100_R103","doi-asserted-by":"crossref","unstructured":"Mok JY, Waugh PR, Simpson H. Mycoplasma pneumonia infection. A follow-up study of 50 children with respiratory illness. Arch Dis Child.1979;54:506\u2013511","DOI":"10.1136\/adc.54.7.506"},{"key":"2021121003391260100_R104","doi-asserted-by":"crossref","unstructured":"Ford MJ, Telfer Brunton WA, Millar J, Stewart C, Critchley JA. Mycoplasma pneumonia: failure of erythromycin therapy. Scott Med J.1980;25:126\u2013128","DOI":"10.1177\/003693308002500208"},{"key":"2021121003391260100_R105","doi-asserted-by":"crossref","unstructured":"McCracken GH, Jr. Current status of antibiotic treatment for Mycoplasma pneumoniae infections. Pediatr Infect Dis.1986;5:167\u2013171","DOI":"10.1097\/00006454-198601000-00054"},{"key":"2021121003391260100_R106","doi-asserted-by":"crossref","unstructured":"Niitu Y, Hasegawa S, Suetake T, Kubota H, Komatsu S, Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr.1970;76:438\u2013443","DOI":"10.1016\/S0022-3476(70)80485-1"},{"key":"2021121003391260100_R107","doi-asserted-by":"crossref","unstructured":"Shames JM, George RB, Holliday WB, Rasch JR, Mogabgab WJ. Comparison of antibiotics in the treatment of Mycoplasmal pneumonia. Arch Intern Med.1970;125:680\u2013684","DOI":"10.1001\/archinte.125.4.680"},{"key":"2021121003391260100_R108","doi-asserted-by":"crossref","unstructured":"Smith DB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med.1967;276:1172\u20131175","DOI":"10.1056\/NEJM196705252762103"},{"key":"2021121003391260100_R109","doi-asserted-by":"crossref","unstructured":"Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J.2000;16:1142\u20131146","DOI":"10.1034\/j.1399-3003.2000.16f21.x"},{"key":"2021121003391260100_R110","doi-asserted-by":"crossref","unstructured":"Renaudin H, Bebear C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis.1990;9:838\u2013841","DOI":"10.1007\/BF01967388"},{"key":"2021121003391260100_R111","doi-asserted-by":"crossref","unstructured":"Marc E, Chaussain M, Moulin F, et al. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr Infect Dis J.2000;19:706\u2013710","DOI":"10.1097\/00006454-200008000-00007"},{"key":"2021121003391260100_R112","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Red Book 2000: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000"},{"key":"2021121003391260100_R113","doi-asserted-by":"crossref","unstructured":"Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. In vitro activity of trovafloxacin compared to those of five antimicrobials against Mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother.2000;44:2557\u20132560","DOI":"10.1128\/AAC.44.9.2557-2560.2000"},{"key":"2021121003391260100_R114","doi-asserted-by":"crossref","unstructured":"Cohen MA, Huband MD. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs. J Antimicrob Chemother.1997;40:308\u2013309","DOI":"10.1093\/jac\/40.2.308"},{"key":"2021121003391260100_R115","doi-asserted-by":"crossref","unstructured":"Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother.2000;45(Suppl 1):29\u201333","DOI":"10.1093\/jac\/45.suppl_3.29"},{"key":"2021121003391260100_R116","doi-asserted-by":"crossref","unstructured":"File TM, Jr, Schlemmer B, Garau J, Cupo M, Young C. The 049 Clinical Study G. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J Antimicrob Chemother.2001;48:67\u201374","DOI":"10.1093\/jac\/48.1.67"},{"key":"2021121003391260100_R117","doi-asserted-by":"crossref","unstructured":"Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother.2001;45:2604\u20132608","DOI":"10.1128\/AAC.45.9.2604-2608.2001"},{"key":"2021121003391260100_R118","doi-asserted-by":"crossref","unstructured":"Gucuyener K, Simsek F, Yilmaz O, Serdaroglu A. Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. Indian J Pediatr.2000;67:467\u2013469","DOI":"10.1007\/BF02859473"},{"key":"2021121003391260100_R119","doi-asserted-by":"crossref","unstructured":"Smith R, Eviatar L. Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six cases and review of the literature. Clin Pediatr (Phila).2000;39:195\u2013201","DOI":"10.1177\/000992280003900401"},{"key":"2021121003391260100_R120","doi-asserted-by":"crossref","unstructured":"Lyon GM, Alspaugh JA, Meredith FT, et al. Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. Chest.1997;112:1428\u20131432","DOI":"10.1378\/chest.112.5.1428"},{"key":"2021121003391260100_R121","doi-asserted-by":"crossref","unstructured":"Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis.1988;10:602\u2013613","DOI":"10.1093\/clinids\/10.3.602"},{"key":"2021121003391260100_R122","doi-asserted-by":"crossref","unstructured":"McMahon DK, Dummer JS, Pasculle AW, Cassell G. Extragenital Mycoplasma hominis infections in adults. Am J Med.1990;89:275\u2013281","DOI":"10.1016\/0002-9343(90)90338-E"},{"key":"2021121003391260100_R123","unstructured":"Mufson MA. Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis.1983;10(Suppl 4):335\u2013340"},{"key":"2021121003391260100_R124","doi-asserted-by":"crossref","unstructured":"Norton R. Mycoplasma hominis pneumonia. Med J Aust.1993;158:361\u2013362","DOI":"10.5694\/j.1326-5377.1993.tb121814.x"},{"key":"2021121003391260100_R125","unstructured":"Rylander M, Hallander HO. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis Suppl.1988;53:12\u201317"},{"key":"2021121003391260100_R126","doi-asserted-by":"crossref","unstructured":"Cummings MC, McCormack WM. Increase in resistance of Mycoplasma hominis to tetracyclines. Antimicrob Agents Chemother.1990;34:2297\u20132299","DOI":"10.1128\/AAC.34.12.2297"},{"key":"2021121003391260100_R127","doi-asserted-by":"crossref","unstructured":"Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines. Antimicrob Agents Chemother.1994;38:2628\u20132632","DOI":"10.1128\/AAC.38.11.2628"},{"key":"2021121003391260100_R128","doi-asserted-by":"crossref","unstructured":"Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99, 219). Antimicrob Agents Chemother.1996;40:1048\u20131049","DOI":"10.1128\/AAC.40.4.1048"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/1\/87\/1002406\/pe0703000087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/1\/87\/1002406\/pe0703000087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T10:41:42Z","timestamp":1639132902000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/1\/87\/63381\/Mycoplasma-Disease-and-Acute-Chest-Syndrome-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,1]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,7,1]]},"published-print":{"date-parts":[[2003,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.1.87","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,1]]}}}